Patent intelligence · US
US 8217166
Polyethylene glycolated superoxide dismutase mimetics
Polyethylene glycolated superoxide dismutase mimetics
Patent details — US 8217166
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jul 10, 2012
- Expiration
- Jul 5, 2032
- Applicant
- Galera Therapeutics, LLC
- Claims
- 92
- CPC classes
- A61K, A61K47/60, A61P, A61P25/00
Quick answer
US 8217166 (Polyethylene glycolated superoxide dismutase mimetics) is held by Galera Therapeutics, LLC. Status: granted. Granted Jul 10, 2012. Expires Jul 5, 2032 (6 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Galera Therapeutics, LLC
- Grant date
- Expiration
- Claims
- 92
- CPC classes
- A61K, A61K47/60, A61P, A61P25/00, A61P37/00
More from Galera Therapeutics, LLC
Related pharmaceutical patents in our USPTO index.
-
US 12220420
Combination therapy for cancer treatment
granted -
US 12156863
Combination cancer therapy with pentaaza macrocyclic ring complex and ascorbate compound
granted -
US 12077549
Pentaaza macrocyclic ring complexes possessing oral bioavailability
granted -
US 11826373
Methods for treatment of diseases
granted -
US 11612608
Methods of treating oral mucositis
granted -
US 11246950
Combination cancer immunotherapy with pentaaza macrocyclic ring complex
granted -
US 11219614
Combination cancer therapy with pentaaza macrocyclic ring complex and ascorbate compound
granted -
US 11066433
Pentaaza macrocyclic ring complexes possessing oral bioavailability
granted
Frequently asked questions
What is US patent 8217166?
US 8217166 (Polyethylene glycolated superoxide dismutase mimetics) is held by Galera Therapeutics, LLC. Status: granted. Granted Jul 10, 2012. Expires Jul 5, 2032 (6 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 8217166?
Galera Therapeutics, LLC is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 23 pharmaceutical patents for this assignee.
When does US 8217166 expire?
Our index shows an expiration date of Jul 5, 2032 (6 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.